KanonCure is a manufacturing company that develops and markets regenerative medicine products and pharmaceuticals for digestive disorders.
KanonCure has raised $4.6M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in August 2021.
KanonCure's investors include CEJ Capital, Green Core, JR West Innovations, Cyberdyne, Yonago Shinkin Bank.
KanonCure is headquartered in Yonago, Japan.
KanonCure is a manufacturing company that develops and markets regenerative medicine products and pharmaceuticals for digestive disorders.
KanonCure is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"KanonCure — Funding & Investors." VCBacked, August 5, 2021, https://www.vcbacked.co/company/kanoncure. Accessed September 30, 2026.
VCBacked. (2021). KanonCure — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/kanoncure
{{cite web |title=KanonCure — Funding & Investors |url=https://www.vcbacked.co/company/kanoncure |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated